Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Novavax Inc

NASDAQ: NVAX · Life Sciences · 3 alerts · CIK 1000694

Share price
$8.06Close, Nov 16
Market cap
$1.33B
Shares outstanding
165.01MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Novavax Inc filings on SEC EDGAR ↗

4:30 PM ET 8-K
Business Update

Novavax Business Update

Novavax earned a $125 million milestone payment from Sanofi following the dosing of the fifth patient in a Phase 3 influenza-COVID-19 combination vaccine trial in the European Union. The trial utilizes Novavax's Nuvaxovid COVID-19 component in combination with Sanofi's high-dose flu vaccine. Novavax expects to receive the payment by the first quarter of 2027 and remains eligible for further clinical and regulatory milestones.

Counterparty
Sanofi Pasteur Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.